NTU spinoff raises $5m to bolster stroke, accident care wearable

Photo credit: Synphne

A medtech spinoff from Nanyang Technological University (NTU) Singapore is looking to expand the presence of its rehabilitation services in the US with a fresh US$5 million raise.

Called Synphne, the company aims to improve the treatment of stroke and neurological conditions.

Its core product is a wearable device that aids in the rehabilitation of individuals suffering from illnesses like stroke as well as brain injuries. Aside from the US, it also aims to tackle Singapore and India, among other markets.

Synphne uses a blend of neural feedback, gamification, and data analytics to provide a customized and real-time perspective on a patient’s recovery process. This method allows users to undergo rehabilitation in both clinical and home environments.

One of the company’s backers in the series A round is Event Horizon Technologies, an affiliate of the Nadathur Group. The group is the family office of Nadathur Raghavan, co-founder of digital services and consulting firm Infosys.

Synphne was incubated under the NTUitive program and has received support from various Singaporean research and enterprise initiatives, including the Singapore-MIT Alliance for Research and Technology, the National Medical Research Council, and the National Research Foundation.

See also: Alodokter sees stagnant revenue, cuts losses by half in 2022